Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 159

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Targeted delivery of therapeutic agents to the heart

Open access
Sahoo, Susmita, Kariya, Taro, Ishikawa, Kiyotake · 2021 · Nature Reviews Cardiology

Abstract

For therapeutic materials to be successfully delivered to the heart, several barriers need to be overcome, including the anatomical challenges of access, the mechanical force of the blood flow, the endothelial barrier, the cellular barrier and the immune response. Various vectors and delivery methods have been proposed to improve the cardiac-specific uptake of materials to modify gene expression. Viral and non-viral vectors are widely used to deliver genetic materials, but each has its respective advantages and shortcomings. Adeno-associated viruses have emerged as one of the best tools for heart-targeted gene delivery. In addition, extracellular vesicles, including exosomes, which are secreted by most cell types, have gained popularity for drug delivery to several organs, including the heart. Accumulating evidence suggests that extracellular vesicles can carry and transfer functional proteins and genetic materials into target cells and might be an attractive option for heart-targeted delivery. Extracellular vesicles or artificial carriers of non-viral and viral vectors can be bioengineered with immune-evasive and cardiotropic properties. In this Review, we discuss the latest strategies for targeting and delivering therapeutic materials to the heart and how the knowledge of different vectors and delivery methods could successfully translate cardiac gene therapy into the clinical setting. For therapeutic materials to be delivered to the heart, several barriers need to be overcome. In this Review, Ishikawa and colleagues discuss strategies for targeted delivery of therapeutic materials to the heart, including the use of adeno-associated viruses and exosomes, with a focus on agents directed at modifying gene expression. Therapies directed at modifying gene expression are emerging and have shown positive results for non-cardiac diseases in clinical trials; clinical translation of these therapies for cardiac diseases remains slow. Currently, cardiac-specific delivery of therapeutic materials in large mammals requires invasive approaches, and the patterns of distribution depend on the delivery method used. Vector options for gene delivery are increasing; adeno-associated viruses provide safe gene delivery but their gene-transduction efficacy in the human heart remains suboptimal. Extracellular vesicles hold immense potential for the delivery of therapeutic agents; their clinical applications depend on their efficient isolation, scalability, drug loading, biodistribution and tissue targeting. Next-generation cardiovascular therapeutics might include bioengineered macromolecules, viruses, nanobiologics and extracellular vesicles. Therapies directed at modifying gene expression are emerging and have shown positive results for non-cardiac diseases in clinical trials; clinical translation of these therapies for cardiac diseases remains slow. Currently, cardiac-specific delivery of therapeutic materials in large mammals requires invasive approaches, and the patterns of distribution depend on the delivery method used. Vector options for gene delivery are increasing; adeno-associated viruses provide safe gene delivery but their gene-transduction efficacy in the human heart remains suboptimal. Extracellular vesicles hold immense potential for the delivery of therapeutic agents; their clinical applications depend on their efficient isolation, scalability, drug loading, biodistribution and tissue targeting. Next-generation cardiovascular therapeutics might include bioengineered macromolecules, viruses, nanobiologics and extracellular vesicles.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41569-020-00499-9

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 159

Metadata

Authors
Sahoo, S., Kariya, T., & Ishikawa, K.
Venue
Nature Reviews Cardiology
Published
2021-01-26
Volume
18
Issue
6
Pages
389-399
ISSN
  • 1759-5002 (ISSN-L)
  • 1759-5010
OpenAlex
W3121527138
Cited by
159
References
16
FWCI
3.89
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeted delivery of therapeutic agents to the heart. https://app.cochat.ai/papers/10.1038/s41569-020-00499-9
The paper
Sahoo, S., Kariya, T., & Ishikawa, K. (2021). Targeted delivery of therapeutic agents to the heart. Nature Reviews Cardiology. https://doi.org/10.1038/s41569-020-00499-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.